Sisi Chan

Investors quietly pile into a group of stocks for 2026 (it’s not tech)

As early as 2026, the healthcare sector is quietly outshining the tech sector in the investment realm. Contrary to mainstream focus, healthcare stocks offer a promising growth trajectory.

Key Points

Healthcare stocks display a silent yet strong performance, with investors potentially underestimating their worth. The upward momentum springs from a range of drivers, worth noting for prospective investors.

Historically, author Todd Campbell has been following sector trends since his inaugural business days. His expertise seeded the creation of a proprietary stocks and sector ranking tool, the Limelight Alpha, which has proven instrumental for sector analysis.

Limelight Alpha Sector Ranking (December 27 2025)

Healthcare stocks have been slowly surpassing the tech sector since the summer of 2025. This trend holds inspite of a major tech presence in indexes like the S&P 500.

Diversification isn’t a bad thing, and healthcare could be the sector to target in 2026

While tech stocks have been ruling the roost, they draw parallels with the Internet boom. The potential for a tech slowdown does not pose an overarching threat. Yet, the pivot towards diversification into neglected sectors is a wise move.

Ranking data shows quiet shift toward healthcare

The author’s sector model, reviewing scores on a whopping 1,600 stocks by industry and sector, demonstrates an undeniably silent rally in major pharmaceutical companies.

Is it too late to buy healthcare stocks?

The argument goes for the favor of healthcare stocks which historically perform best during the late business cycle stages. Regulatory hazards are viewed as excessive fear, and favorable winds blow in the direction of rising M&A activities and falling interest rates.